Who Buys Voriconazole from India — 393 Importers Behind a $31.3M Market
India's voriconazole import market is served by 393 active buyers who collectively imported $31.3M across 1,413 shipments. SOBUS LTD (GEORGIA) leads with a 17.8% market share, followed by SANDOZ(CHINA)PHARMACEUTICAL CO.,LTD and EVERSANA LIFE SCIENCE SERVICES. The top 5 buyers together control 41.0% of total import value, reflecting a moderately competitive buyer landscape.

Top Voriconazole Importers — Ranked by Import Value
SOBUS LTD (GEORGIA) is the leading voriconazole importer from India, holding a 17.8% share of the $31.3M market across 1,413 shipments from 393 buyers. The top 5 buyers — SOBUS LTD (GEORGIA), SANDOZ(CHINA)PHARMACEUTICAL CO.,LTD (CHINA), EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), AJANTA PHARMA USA INC. C/O RXCROSSR (UNITED STATES), FAWDON MANUFACTURING CENTRE ( SF ) (UNITED KINGDOM) — collectively control 41.0% of total import value.
Top Voriconazole Buyers & Importers
Ranked by import value · 393 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | SOBUS LTDGEORGIA VORIFLAN 200 MG. B.: AL5001 M. 03/2025 E.: 02/2027VORIFLA 25 ML. | $5.6M | 5 | 17.8% |
| 2 | SANDOZ(CHINA)PHARMACEUTICAL CO.,LTDCHINA MATERIAL NO. - 44087965, VORICONAZOLE 20MATERIAL NO- 44087965 VORICONAZOLE 200MG30FCT CNMATERIAL NO.-44087965, VORICONAZOLE 200M | $4.2M | 5 | 13.6% |
| 3 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $1.2M | 5 | 3.7% |
| 4 | AJANTA PHARMA USA INC. C/O RXCROSSRUNITED STATES VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $934.4K | 5 | 3.0% |
| 5 | FAWDON MANUFACTURING CENTRE ( SF )UNITED KINGDOM VORICONAZOLE FC TABS 200MG 28S 2X14S UK 4195X28S=117460NOSVORICONAZOLE FC TABS 200 MG 28S | $881.3K | 5 | 2.8% |
| 6 | FRESENIUS KABI USA, LLCUNITED STATES VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $587.3K | 5 | 1.9% |
| 7 | SANDOZ CHINA PHARMACEUTICAL COCHINA MATERIAL NO. - 44087965, VORICONAZOLE 20MATERIAL NO- 44087965 VORICONAZOLE 200MG30FCT CNVORICONAZOLE FOR INJECTION 200MG/VIAL, 3 | $534.6K | 5 | 1.7% |
| 8 | MOVIANTO UK LTDUNITED KINGDOM VORICONAZOLE FC TABS 200MG 28S 2X14S UK 4195X28S=117460NOSVORICONAZOLE FC TABS 200 MG 28S | $489.7K | 5 | 1.6% |
| 9 | LEK D.DSLOVENIA MATERIAL NO. - 42026721 VORICONAZOLE FCT200MG IN91 SH EUMATERIAL NO. - 42026721,VORICONAZOLE FCTVORICONAZOLE FCT 200MG IN91 SH EU MATERIAL NO. - 42026721 | $446.7K | 5 | 1.4% |
| 10 | ALMAJECTUNITED STATES VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $444.3K | 5 | 1.4% |
| 11 | MSN LABS AMERICAS SASCOLOMBIA VORICONAZOLE 200MG INJ DRL-BRAVORIOLE 200 1X10VORICONAZOLE 200MG INJ 1X1S DRL-BRA | $424.7K | 5 | 1.4% |
| 12 | AJANTA PHARMA USA INCUNITED STATES VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $397.1K | 5 | 1.3% |
| 13 | SANDOZ INC. C/O EXEL, INC.UNITED STATES MATERIAL NO. - 44087965, VORICONAZOLE 20MATERIAL NO- 44087965 VORICONAZOLE 200MG30FCT CNVORICONAZOLE FOR INJECTION 200MG/VIAL, 3 | $382.9K | 5 | 1.2% |
| 14 | DR.REDDYS FARMACEUTICA DO BRASIL LBRAZIL VORICONAZOLE 200MG INJ DRL-BRAVORICONAZOLE 200MG INJ 1X1S DRL-BRAVORICONAZOLE 200MG/VIAL VLS | $360.8K | 5 | 1.2% |
| 15 | AJANTA PHARMA USA INC C O RXCROSSRUNITED STATES VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $359.9K | 5 | 1.2% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Voriconazole — and from which countries?
Flow of Voriconazole exports from India: each country's share and the named importers behind the numbers
Voriconazole — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1China
China emerges as the first largest importing country, achieving a total trade value of $6.3M through 78 shipments. This represents a market share of 20.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: China has a diverse importer base, with their top importers including:
• SANDOZ(CHINA)PHARMACEUTICAL CO.,LTD - $4.2M (67.8% of country's total business)
• SANDOZ CHINA PHARMACEUTICAL CO - $534.6K (8.5% of country's total business)
• SANDOZ CHINA PHARMACEUTICAL CO LIMITED - $327.4K (5.2% of country's total business)
• SANDOZ (CHINA) PHARMACEUTICAL CO.,L - $327.2K (5.2% of country's total business)
Key Insight: China demonstrates strong market positioning with an average shipment value of $80.2K, indicating premium pricing strategy compared to the market average of $22.1K.
China is a key market for Voriconazole imports, representing 20.0% of total trade value.
2United States
United States emerges as the second largest importing country, achieving a total trade value of $5.8M through 52 shipments. This represents a market share of 18.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $1.2M (20.1% of country's total business)
• AJANTA PHARMA USA INC. C/O RXCROSSR - $934.4K (16.0% of country's total business)
• FRESENIUS KABI USA, LLC - $587.3K (10.1% of country's total business)
• ALMAJECT - $444.3K (7.6% of country's total business)
• AJANTA PHARMA USA INC - $397.1K (6.8% of country's total business)
• Rest of United States's importers - $2.3M (39.4% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $112.0K, indicating premium pricing strategy compared to the market average of $22.1K.
United States is a key market for Voriconazole imports, representing 18.6% of total trade value.
3Georgia
Georgia emerges as the third largest importing country, achieving a total trade value of $5.6M through 4 shipments. This represents a market share of 17.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Georgia has a diverse importer base, with their top importers including:
• SOBUS LTD - $5.6M (100.0% of country's total business)
Key Insight: Georgia demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $22.1K.
Georgia is a key market for Voriconazole imports, representing 17.8% of total trade value.
4United Kingdom
United Kingdom emerges as the fourth largest importing country, achieving a total trade value of $2.4M through 30 shipments. This represents a market share of 7.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• FAWDON MANUFACTURING CENTRE ( SF ) - $881.3K (36.8% of country's total business)
• MOVIANTO UK LTD - $489.7K (20.4% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $79.8K, indicating premium pricing strategy compared to the market average of $22.1K.
United Kingdom is a key market for Voriconazole imports, representing 7.7% of total trade value.
5Brazil
Brazil emerges as the fifth largest importing country, achieving a total trade value of $1.4M through 8 shipments. This represents a market share of 4.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• DR.REDDYS FARMACEUTICA DO BRASIL L - $360.8K (26.2% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $172.2K, indicating premium pricing strategy compared to the market average of $22.1K.
Brazil is a key market for Voriconazole imports, representing 4.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Voriconazole buyer market intelligence
1Buyer Segment Analysis
The 393 buyers of Voriconazole from India can be categorized into several segments:
- Distributors: Entities like SOBUS LTD (Georgia) and MOVIANTO UK LTD (United Kingdom) function as intermediaries, purchasing Voriconazole in bulk and supplying it to healthcare providers and pharmacies. Their buying behavior is characterized by large, regular orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as FAWDON MANUFACTURING CENTRE (SF) in the United Kingdom procure Voriconazole directly for inpatient treatments. Their purchasing patterns are influenced by patient demand and formulary requirements, often resulting in consistent, sizable orders.
- Retail Chains: Companies like AJANTA PHARMA USA INC. C/O RXCROSSR (United States) acquire Voriconazole to stock their pharmacy outlets, ensuring availability for outpatient prescriptions. Their orders are typically smaller and more frequent, aligning with retail sales trends.
- Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations often engage in tender-based purchasing to supply public health facilities. Their procurement processes are formal and competitive, aiming to secure large quantities at optimal prices.
- Re-exporters: Some buyers may act as re-exporters, purchasing Voriconazole from India to supply other markets. This segment's buying behavior is driven by global demand fluctuations and trade agreements.
- Contract Manufacturers: Entities like LEK D.D (Slovenia) may procure Voriconazole as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their orders are typically large and aligned with production schedules.
Country-Specific Import Regulations
TransData Nexus Voriconazole buyer market intelligence
1Country-Specific Import Regulations
China
1. Regulatory Authority: National Medical Products Administration (NMPA).
2. Import Registration Process: Importers must submit a drug registration application to the NMPA, including comprehensive documentation on product quality, safety, and efficacy.
3. Estimated Timeline: The registration process can take approximately 12 to 24 months, depending on the completeness of the application and any additional requirements.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are subject to an import duty of 5%, with potential value-added tax (VAT) applicable.
United States
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Voriconazole is FDA-approved. The process involves submitting an Abbreviated New Drug Application (ANDA) or a New Drug Application (NDA), along with compliance with Current Good Manufacturing Practices (cGMP).
3. Estimated Timeline: The approval process can range from 10 to 18 months, depending on the application type and review process.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049029 are generally duty-free, but importers should verify current trade policies.
Georgia
1. Regulatory Authority: State Regulation Agency for Medical Activities under the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia.
2. Import Registration Process: Importers must register the pharmaceutical product with the agency, providing documentation on quality, safety, and efficacy.
3. Estimated Timeline: The registration process typically takes 6 to 12 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are subject to an import duty of 0%, as Georgia has a liberal trade regime for pharmaceuticals.
United Kingdom
1. Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from the MHRA, which involves submitting a comprehensive dossier demonstrating the product's quality, safety, and efficacy.
3. Estimated Timeline: The MA process can take approximately 12 to 24 months.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049029 are generally duty-free, but importers should confirm current trade agreements and tariffs.
Brazil
1. Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
2. Import Registration Process: Importers must register the pharmaceutical product with ANVISA, providing detailed information on the product's quality, safety, and efficacy.
3. Estimated Timeline: The registration process can take 12 to 18 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are subject to an import duty of 8%, with additional taxes such as the Industrialized Product Tax (IPI) and Social Integration Program (PIS) tax applicable.
Demand Drivers & Market Opportunity
TransData Nexus Voriconazole buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Voriconazole in importing countries is primarily driven by the prevalence of invasive fungal infections, particularly among immunocompromised patients, such as those undergoing chemotherapy, organ transplantation, or suffering from HIV/AIDS. The inclusion of Voriconazole in the World Health Organization's Model List of Essential Medicines underscores its critical role in treating serious fungal infections, thereby influencing procurement decisions by governments and healthcare organizations. (who.int)
Government healthcare programs and the expansion of universal health coverage have also contributed to increased demand. For instance, initiatives by organizations like the Global Fund to Fight AIDS, Tuberculosis and Malaria have facilitated the procurement of essential medicines, including antifungals, through pooled procurement mechanisms, enhancing accessibility and affordability. Tender-based purchasing remains a common practice, allowing large-scale buyers to negotiate favorable terms, ensuring a steady supply of Voriconazole to meet public health needs.
Common Questions — Voriconazole Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest voriconazole buyer importing from India?
Based on import volume and value, SOBUS LTD (GEORGIA) leads with $5.6M in imports and a 17.8% market share — the highest of any single voriconazole importer. SANDOZ(CHINA)PHARMACEUTICAL CO.,LTD (CHINA) and EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) are the next largest buyers.
QHow many companies buy voriconazole from India?
There are 393 active voriconazole buyers importing from India, with a combined market of $31.3M across 1,413 shipments to 114 countries. The top 5 buyers hold 41.0% of total import value, while the remaining 388 buyers handle the other 59.0%.
QWhich countries import the most voriconazole from India?
The top importing countries for voriconazole from India are China (20.0%), United States (18.6%), Georgia (17.8%), United Kingdom (7.7%), Brazil (4.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of voriconazole, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for voriconazole from India?
The average import transaction value for voriconazole from India is $22.1K, with an average unit price of $11.41 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Voriconazole buyer market intelligence
1Buyer Segment Analysis
The 393 buyers of Voriconazole from India can be categorized into several segments:
- Distributors: Entities like SOBUS LTD (Georgia) and MOVIANTO UK LTD (United Kingdom) function as intermediaries, purchasing Voriconazole in bulk and supplying it to healthcare providers and pharmacies. Their buying behavior is characterized by large, regular orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as FAWDON MANUFACTURING CENTRE (SF) in the United Kingdom procure Voriconazole directly for inpatient treatments. Their purchasing patterns are influenced by patient demand and formulary requirements, often resulting in consistent, sizable orders.
- Retail Chains: Companies like AJANTA PHARMA USA INC. C/O RXCROSSR (United States) acquire Voriconazole to stock their pharmacy outlets, ensuring availability for outpatient prescriptions. Their orders are typically smaller and more frequent, aligning with retail sales trends.
- Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations often engage in tender-based purchasing to supply public health facilities. Their procurement processes are formal and competitive, aiming to secure large quantities at optimal prices.
- Re-exporters: Some buyers may act as re-exporters, purchasing Voriconazole from India to supply other markets. This segment's buying behavior is driven by global demand fluctuations and trade agreements.
- Contract Manufacturers: Entities like LEK D.D (Slovenia) may procure Voriconazole as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their orders are typically large and aligned with production schedules.
Country-Specific Import Regulations
TransData Nexus Voriconazole buyer market intelligence
1Country-Specific Import Regulations
China
1. Regulatory Authority: National Medical Products Administration (NMPA).
2. Import Registration Process: Importers must submit a drug registration application to the NMPA, including comprehensive documentation on product quality, safety, and efficacy.
3. Estimated Timeline: The registration process can take approximately 12 to 24 months, depending on the completeness of the application and any additional requirements.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are subject to an import duty of 5%, with potential value-added tax (VAT) applicable.
United States
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Voriconazole is FDA-approved. The process involves submitting an Abbreviated New Drug Application (ANDA) or a New Drug Application (NDA), along with compliance with Current Good Manufacturing Practices (cGMP).
3. Estimated Timeline: The approval process can range from 10 to 18 months, depending on the application type and review process.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049029 are generally duty-free, but importers should verify current trade policies.
Georgia
1. Regulatory Authority: State Regulation Agency for Medical Activities under the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia.
2. Import Registration Process: Importers must register the pharmaceutical product with the agency, providing documentation on quality, safety, and efficacy.
3. Estimated Timeline: The registration process typically takes 6 to 12 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are subject to an import duty of 0%, as Georgia has a liberal trade regime for pharmaceuticals.
United Kingdom
1. Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from the MHRA, which involves submitting a comprehensive dossier demonstrating the product's quality, safety, and efficacy.
3. Estimated Timeline: The MA process can take approximately 12 to 24 months.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049029 are generally duty-free, but importers should confirm current trade agreements and tariffs.
Brazil
1. Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
2. Import Registration Process: Importers must register the pharmaceutical product with ANVISA, providing detailed information on the product's quality, safety, and efficacy.
3. Estimated Timeline: The registration process can take 12 to 18 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049029 are subject to an import duty of 8%, with additional taxes such as the Industrialized Product Tax (IPI) and Social Integration Program (PIS) tax applicable.
Demand Drivers & Market Opportunity
TransData Nexus Voriconazole buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Voriconazole in importing countries is primarily driven by the prevalence of invasive fungal infections, particularly among immunocompromised patients, such as those undergoing chemotherapy, organ transplantation, or suffering from HIV/AIDS. The inclusion of Voriconazole in the World Health Organization's Model List of Essential Medicines underscores its critical role in treating serious fungal infections, thereby influencing procurement decisions by governments and healthcare organizations. (who.int)
Government healthcare programs and the expansion of universal health coverage have also contributed to increased demand. For instance, initiatives by organizations like the Global Fund to Fight AIDS, Tuberculosis and Malaria have facilitated the procurement of essential medicines, including antifungals, through pooled procurement mechanisms, enhancing accessibility and affordability. Tender-based purchasing remains a common practice, allowing large-scale buyers to negotiate favorable terms, ensuring a steady supply of Voriconazole to meet public health needs.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 393 global importers of Voriconazole identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,413 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 114 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,413 Verified Shipments
393 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists